DE602006021048D1 - Behandlung von akutem nierenversagen mit löslichem thrombomodulin - Google Patents

Behandlung von akutem nierenversagen mit löslichem thrombomodulin

Info

Publication number
DE602006021048D1
DE602006021048D1 DE602006021048T DE602006021048T DE602006021048D1 DE 602006021048 D1 DE602006021048 D1 DE 602006021048D1 DE 602006021048 T DE602006021048 T DE 602006021048T DE 602006021048 T DE602006021048 T DE 602006021048T DE 602006021048 D1 DE602006021048 D1 DE 602006021048D1
Authority
DE
Germany
Prior art keywords
soluble thrombomodulin
treatment
kidney failure
acute kidney
thrombomodulin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602006021048T
Other languages
German (de)
English (en)
Inventor
Brian William Grinnell
Thurman Dwight Mckinney
Bruce A Molitoris
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of DE602006021048D1 publication Critical patent/DE602006021048D1/de
Anticipated expiration legal-status Critical
Active legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE602006021048T 2005-10-13 2006-10-12 Behandlung von akutem nierenversagen mit löslichem thrombomodulin Active DE602006021048D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72637605P 2005-10-13 2005-10-13
PCT/US2006/040069 WO2007047430A2 (en) 2005-10-13 2006-10-12 Method of treating acute failure with thrombomodulin variant

Publications (1)

Publication Number Publication Date
DE602006021048D1 true DE602006021048D1 (de) 2011-05-12

Family

ID=37670944

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602006021048T Active DE602006021048D1 (de) 2005-10-13 2006-10-12 Behandlung von akutem nierenversagen mit löslichem thrombomodulin

Country Status (13)

Country Link
US (1) US20080255047A1 (cg-RX-API-DMAC7.html)
EP (1) EP1948216B1 (cg-RX-API-DMAC7.html)
JP (1) JP5405829B2 (cg-RX-API-DMAC7.html)
AT (1) ATE503489T1 (cg-RX-API-DMAC7.html)
CA (1) CA2625888C (cg-RX-API-DMAC7.html)
CY (1) CY1112438T1 (cg-RX-API-DMAC7.html)
DE (1) DE602006021048D1 (cg-RX-API-DMAC7.html)
DK (1) DK1948216T3 (cg-RX-API-DMAC7.html)
ES (1) ES2360610T3 (cg-RX-API-DMAC7.html)
PL (1) PL1948216T3 (cg-RX-API-DMAC7.html)
PT (1) PT1948216E (cg-RX-API-DMAC7.html)
SI (1) SI1948216T1 (cg-RX-API-DMAC7.html)
WO (1) WO2007047430A2 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008073884A2 (en) * 2006-12-12 2008-06-19 Eli Lilly And Company Treating acute renal failure with soluble thrombomodulin variants
WO2010056472A2 (en) * 2008-11-12 2010-05-20 Eli Lilly And Company Compositions and methods of use for thrombomodulin variants

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2022713A1 (en) * 1989-08-11 1991-02-12 Nils U. Bang Human thrombomodulin derivatives
DE69333491T2 (de) * 1992-02-05 2005-03-31 Paion Gmbh Protease-Resistant Thrombomodulin Analogs
ATE249234T1 (de) * 1993-12-17 2003-09-15 Mochida Pharm Co Ltd Lösliches thrombomodulin enthaltende zubereitung
CA2515916A1 (en) * 2003-02-25 2004-09-10 Biovec B.V. Therapeutic applications of thrombomodulin gene via viral and non-viral vectors

Also Published As

Publication number Publication date
CA2625888A1 (en) 2007-04-26
CA2625888C (en) 2015-09-22
PL1948216T3 (pl) 2011-10-31
ES2360610T3 (es) 2011-06-07
WO2007047430A8 (en) 2008-04-10
EP1948216B1 (en) 2011-03-30
WO2007047430A3 (en) 2007-05-24
PT1948216E (pt) 2011-05-06
JP2009511597A (ja) 2009-03-19
JP5405829B2 (ja) 2014-02-05
EP1948216A2 (en) 2008-07-30
CY1112438T1 (el) 2015-12-09
SI1948216T1 (sl) 2011-07-29
US20080255047A1 (en) 2008-10-16
WO2007047430A2 (en) 2007-04-26
ATE503489T1 (de) 2011-04-15
DK1948216T3 (da) 2011-06-06

Similar Documents

Publication Publication Date Title
NO20074999L (no) Metode og preparat for behandling av perifere vaskulaere sykdommer
CY1117656T1 (el) Επιλογες θεραπειας για τη νοσο του fabry
BR0308928A (pt) Uso de toxina botulìnica para o tratamento de doenças cardiovasculares, bem como composição para uso em um procedimento cardiovascular
NO20074943L (no) Roflumilast for behandlingen av diabetes mellitus
HRP20110969T1 (en) Pimobendan to be used for the reduction of heart size in mammals suffering from heart failure
DK1301201T3 (da) Behandling af glycogenosis type II
NO20076241L (no) Terapier for vaskulaere sykdommer
EA201100755A1 (ru) Способ лечения или профилактики тромбоза с использованием этексилата дабигатрана или его соли с улучшенной эффективностью по сравнению со стандартным лечением варфарином
DK1809661T3 (da) Humant interferon-beta-mutein
ATE543492T1 (de) Behandlung von lungenkrebs
EA200870091A1 (ru) Применение бензоконденсированных гетероциклических сульфамидных производных для снятия боли
ATE548035T1 (de) Formulierungen zur behandlung von lipoprotein- anormalitäten mit einem statin- und einem methylnicotinamid-derivat
EA200870088A1 (ru) Применение бензоконденсированных гетероциклических сульфамидных производных для понижения уровней липидов и глюкозы в крови
EA200701995A1 (ru) Способы уменьшения кальцификации
DK2022786T3 (da) Middel mod mund- og klovsyge-virus til dyr, der hører til familien suidae eller får, og fremgangsmåde til forebyggelse eller behandling af mund- og klovsyge hos dyr, der hører til familien suidae eller får
EA200700407A1 (ru) Производные хиназолина и их использования при лечении тромбоцитемии
EP2754447A3 (en) Treating acute renal failure with soluble thrombomodulin variants
CY1112438T1 (el) Μεθοδος αγωγης της οξειας νεφρικης ανεπαρκειας με διαλυτη θρομβομοδουλινη
DE50111407D1 (de) Mittel enthaltend n-chlortaurin sowie dessen verwendung zur behandlung von schleimhautpolypen
EA200702201A1 (ru) Рофлумиласт для лечения лёгочной гипертензии
DK1596879T3 (da) Anvendelse af kahalalidforbindelser til fremstilling af et medikament til behandling af psoriasis
TN2011000206A1 (en) Compositions and methods of use soluble thrombomodulin variants
FI20030015A0 (fi) Menetelmä munuaisten vajaatoiminnan hoitamiseksi
ATE454144T1 (de) Behandlung von malignen neoplasien
WO2007117272A3 (en) Methods for treatment of hemorrhagic shock and related disorders